Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N04BC08
CAS registry number (Chemical Abstracts Service)
0003605-01-4
Chemical Formula
C16-H18-N4-O2
Molecular Weight
298
Therapeutic Category
Treatment of Parkinson's disease: Dopaminergic
Chemical Name
Pyrimidine, 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-
Foreign Names
- Piribedilum (Latin)
- Piribedil (German)
- Piribédil (French)
- Piribedil (Spanish)
Generic Names
- Piribedil (OS: DCIT)
- Piribédil (OS: DCF)
- ET 495 (IS)
- EU 4200 (IS)
- Piprazidine (IS)
- Piribedyl (IS)
- S 495 (IS)
- Piribedil methanesulfonate (IS)
Brand Names
- Clarium
Desitin, Germany - Pronoran
Servier, Georgia; Servier, Lithuania; Servier, Latvia; Servier, Poland; Servier, Romania; Servier, Russian Federation - Trastal
Servier, China - Trivastal Retard
Servier, Brazil; Servier, Malta; Servier, Vietnam - Trivastal
Serdia, India; Servier, United Arab Emirates; Servier, Netherlands Antilles; Servier, Argentina; Servier, Aruba; Servier, Barbados; Servier, Bahrain; Servier, Bermuda; Servier, Bahamas; Servier, Egypt; Servier, France; Servier, Grenada; Servier, Guyana; Servier, Iraq; Servier, Jamaica; Servier, Jordan; Servier, Kuwait; Servier, Cayman Islands; Servier, Lebanon; Servier, Saint Lucia; Servier, Luxembourg; Servier, Malta; Servier, Malaysia; Servier, Oman; Servier, Philippines; Servier, Portugal; Servier, Qatar; Servier, Saudi Arabia; Servier, Singapore; Servier, Syria; Servier, Thailand; Servier, Tunisia; Servier, Turkey; Servier, Trinidad & Tobago; Servier, Saint Vincent & The Grenadines; Servier, Venezuela; Servier, Yemen - Trivastan
Servier-F, Italy - Trivastal
Servier, France; Servier, Oman
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment